Biomarkers are key molecular or cellular events that link a specific environmental exposure to a health outcome. Biomarkers play an important role in understanding the relationships between exposure to environmental chemicals, the development of chronic human diseases, and the identification of subgroups that are at increased risk for disease.
https://www.niehs.nih.gov/health/topics/science/biomarkers/index.cfm
View all figures. 1  Figure 1: Volume of immune biomarker publications. 2  Figure 2: Comparison of different medical approaches. 3  Figure 3: Timelines for treatment efficacy in allograft rejection.  Figure 4: The immune biomarker 1  workstream. Figure 5: Decreasing costs of genome sequencing.
http://www.nature.com/nri/journal/v15/n5/full/nri3820.html
All rights reserved. Copyright 1988 Pergamon Press plc CELLULAR BIOMARKERS OF AGING VINCENT J. CRISTOFALO The Wistar Institute, 3601 Spruce Street, Philadelphia, Pennsylvania 19104 Abstract -- Normal human fibroblast-like cells show a declining proliferative capac- ity with age.
http://www.sciencedirect.com/science/article/pii/0531556588900320
Biomarker (cell) For other uses, see Biomarker (disambiguation). A biomarker, or biological marker, is defined as a cellular, biochemical or molecular alteration in cells, tissues or fluids that can be measured and evaluated to indicate normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention..
https://en.wikipedia.org/wiki/Biomarker_(cell)
CELLULAR BIOMARKERS OF AGING 299 TABLE 1. REPLICATIVE LIFE SPAN CHARACTERISTICS OF CELL LINES W1-38 n IMR-90 n PDL to Phase Out 66 --_ 6 36 56 _+ 9 17 (Mean ___ SD) Weeks to Phase Out 25 _ 2.5 36 23 _+ 6 17 Mean _+ SD RESULTS In our studies we determined culture life span by direct cell count.
http://www.sciencedirect.com/science/article/pii/0531556588900320
This presentation will cover: 1) pre-analytical factors have significant influence on clinical biomarker development and qualification, and 2) matrix selection is important in the accurate quantitation of clinical biomarkers. 2:30 Circulating microRNAs as Progression Biomarkers for Parkinson’s Disease.
http://www.biomarkerworldcongress.com/Cell-Free-Biomarkers/
The rise of precision medicine and data intensive medicine are inextricably linked. Academia, industry and healthcare providers are ill-prepared for this data deluge which will impose profound changes in research and clinical care. 9:00 Multi-Stakeholder Progress on Biomarker Qualification.
http://www.biomarkerworldcongress.com/Cell-Free-Biomarkers/
The National Institutes of Health Biomarker Definitions Working Group define a biomarker as “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention” (Ref. 50).
http://www.nature.com/nri/journal/v15/n5/full/nri3820.html
The monitoring efficacy can be greatly improved by using batteries of non-specific biomarkers. comprising different biological levels. Thus, the use of molecular, biochemical and cellular biomarkers has proved. to be very useful in environmental and aquatic pollution monitoring. [Adedeji OB, Okerentugba PO, Okonko IO. Use of Molecular, Biochemical and Cellular Biomarkers in. Monitoring Environmental and Aquatic Pollution.
http://www.sciencepub.net/nature/ns1009/013_9994ns1009_83_104.pdf
Use of Molecular, Biochemical and Cellular Biomarkers in Monitoring Environmental and Aquatic Pollution. Adedeji OB1, Okerentugba PO2, Okonko IO2. 1Department of Veterinary Public Health & Preventive Medicine, University of Ibadan, Ibadan, Nigeria.
http://www.sciencepub.net/nature/ns1009/013_9994ns1009_83_104.pdf
what are cellular biomarkers
Cellular bio-markers are cellular, biochemical or molecular alteration in cells, tissues or fluids that can be measured and evaluated to indicate normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention.